e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Epithelial cell biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of JAK-STAT inhibitors on glucocorticosteroid resistant release of CXCR3 chemokines from human bronchial epithelial cells
P. Fenwick, I. Kilty, M. Yeadon, P. Barnes, L. Donnelly (London, Sandwich, United Kingdom)
Source:
Annual Congress 2011 - Epithelial cell biology
Session:
Epithelial cell biology
Session type:
Poster Discussion
Number:
3097
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Fenwick, I. Kilty, M. Yeadon, P. Barnes, L. Donnelly (London, Sandwich, United Kingdom). Effects of JAK-STAT inhibitors on glucocorticosteroid resistant release of CXCR3 chemokines from human bronchial epithelial cells. Eur Respir J 2011; 38: Suppl. 55, 3097
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Attenuated cytokine response and enhanced toll-like receptor expression by budesonide in bronchial epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 101s
Year: 2006
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
CD40 ligation modulates inflammatory cytokines production by human bronchial epithelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 246s
Year: 2001
CCL5 (RANTES) inhibits TGF-β1-induced collagen production in human bronchial epithelial cells by action of Smad protein
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Effects of long-acting beta2 agonists on Th1 and Th2 chemokines in monocytes and bronchial epithelial cells
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells
Source: Eur Respir J 2008; 31: 1313-1321
Year: 2008
Activation of PAR-2 enhances ICAM-1 expression and IL-8 release in airway epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 571s
Year: 2002
Inhibition of IRAK4 suppresses chemokine release from human bronchial epithelial cells
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
Glucocorticoids enhance CCL20 release in bronchial epithelial cells in a metalloprotease-dependent manner
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Azithromycin augments rhinovirus-induced expression of IFNbeta and IFNλ1 in asthmatic bronchial epithelial cells by up-regulating RIG-I like receptors
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Differentiation of bronchial epithelial cells in the presence of Th2 cytokines increases the expression of the human cathelicidin hCAP18/LL-37
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Modulatory effects of immunosuppressives on IL-8 and GM-CSF expression in bronchial and alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 854s
Year: 2006
Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Source: Eur Respir J 2012; 39: 439-445
Year: 2012
IL-17-induced release of GRO-alpha in human bronchial epithelial cells
in vitro
Source: Eur Respir J 2001; 18: Suppl. 33, 520s
Year: 2001
The muscarinic receptors promote IL-8 release in airway epithelial cells
via
the pERK42/44 and NF-kB pathways
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006
Effects of glucocorticosteroids and antimicrobial drugs on inhibition of IL-1β- and PDBu-induced IL-8 release in the presence of pyocyanin in bronchial epithelial cell line
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005
CysLT1 receptor activation-induced adhesion of human eosinophils to bronchial epithelial cells: signal transduction and pharmacological modulation
Source: Eur Respir J 2005; 26: Suppl. 49, 368s
Year: 2005
Statins suppress LPS-induced proinflammatory cytokine production from human bronchial epithelial cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Rolipram inhibits eotaxin-3 releasing in human epithelial cells BEAS-2B stimulated with Th2 cytokines
Source: Eur Respir J 2007; 30: Suppl. 51, 219s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept